Orange Book product · Brand (NDA)
DEPODUR
MORPHINE SULFATE
At a glance
May 18, 2004
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 18, 2004
22 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
MORPHINE SULFATE
Strength
20MG/2ML (10MG/ML)
Dosage form
INJECTABLE, LIPOSOMAL
Route
EPIDURAL
TE code
Not listed
Application
NDA 021671
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2017ARYMO ERBrand (NDA)
NDA 208603 · ZYLA
- 2015MORPHABOND ERBrand (NDA)
NDA 206544 · OHEMO LIFE
- 2013MORPHINE SULFATEBrand (NDA)
NDA 204223 · FRESENIUS KABI USA
- 2011MORPHINE SULFATEBrand (NDA)
NDA 202515 · HOSPIRA INC
- 2011MORPHINE SULFATEBrand (NDA)
NDA 201517 · CHARTWELL MOLECULAR
- 2008MORPHINE SULFATEBrand (NDA)
NDA 022195 · HIKMA
- 2007KADIANBrand (NDA)
NDA 020616 · ALLERGAN
- 2002AVINZABrand (NDA)
NDA 021260 · KING PHARMS LLC
- 1996MORPHINE SULFATEBrand (NDA)
NDA 020631 · SPECGX LLC
- 1992MORPHINE SULFATEBrand (NDA)
NDA 019917 · ICU MEDICAL INC
- 1992MORPHINE SULFATEBrand (NDA)
NDA 019916 · ICU MEDICAL INC
- 1990MORPHINE SULFATE (AUTOINJECTOR)Brand (NDA)
NDA 019999 · MERIDIAN MEDCL TECHN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
